Skip to main content

Advertisement

Table 1 Baseline characteristics of the population

From: Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: a multicentric cross-sectional study

Population Total n = 1315 Clinical n = 729 Surgical n = 586 p -value
Age (years)* 61.5 (18.7%) 64.5 (18.7%) 57.8 (17.9%) < 0.001
Male gender N (%)** 677 (51.5%, 49-54) 384 (52.7%) 49-56) 293 (50.0%) (46-54) NS
Risk factors n (%)     
Prolonged rest or lower limb paralysis 483 (36.7%) (34-39) 330 (45.3%) 42-49 153 (26.1%) (23-30) < 0.001
Active cancer and/or chemotherapy treatment 272 (20.7%) (18-23) 159 (21.8%) (19-25) 113 (19.3%) 16-22 NS
Overweight (BMI > 25) 267 (20.3%) (18-22) 330 (45.3%) (17-23) 123 (21%) (18-24) NS
Varicose veins or chronic venous insufficiency 112 (8.5%) (7-.1) 68 (9.3%) (7-11) 44 (7.5%) (5-10) NS
Heart failure 111 (8.4%) (7-10) 85 (11.7%) (9-14) 26 (4.4%) (3-6) < 0.001
Central venous catheter 116 (8.4%) (7-10) 61 (8.4%) (63-10) 55 (9.4%) (7-12) NS
Chronic obstructive pulmonary disease 78 (5.9%) (5-7) 61 (8.4%) (6-10) 17 (2.9%) (2-4) <0.001
History of DVT/PE 27 (2.1%) (1-3) 21 (2.9%) (2-4) 6 (1.0%) (2-2) 0.018
Myeloproliferative syndrome 18 (1.4%) 7-2) 17 (2.3%) (1-3) 1 (0.2%) (2-5) < 0.001
Inflammatory disease 15 (1.1%) (0.57-1.7) 11 (1.5%) (1-2) 4 (0.7%) (0.1-1.3) NS
Estrogen therapy 14 (1.1%) 0.5-1.6 7 (1%) (0.2-2) 7 (1.2%) (0.32) NS
Nephrotic syndrome 12 (0.9%) (0.4-1.4) 10 (1.4%) (1-2) 2 (0.3%) (0.1-0.8) NS
Thrombophilia 5 (0.4%) 0.05-0.7 3 (0.4%) (0.1-0.9) 2 (0.3%) (0.13-0.8) NS
  1. *Expressed as the mean and standard deviation (SD).
  2. ** Expressed as proportions and the confidence interval.